New Strategies in the Discovery of Novel Non-Camptothecin Topoisomerase I Inhibitors

By  

Current Medicinal Chemistry, Vol. 18, Iss. 28, 2011-10 ,pp. : 4389-4409

Bentham Science Publishers

Access to resources Recommend Favorite

Camptothecin and Podophyllotoxin Derivatives: Inhibitors of Topoisomerase I and II – Mechanisms of Action, Pharmacokinetics and Toxicity Profile

By Hartmann Jörg T.  

Drug Safety, Vol. 29, Iss. 3, 2006-01 ,pp. : 209-230

Adis International

Access to resources Recommend Favorite

In-silico Designing of Novel Camptothecin Analogues as Potent Inhibitors of Topoisomerase I: A Molecular Docking, QSAR, and ADME-T Study

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 9, 2016-10 ,pp. : 859-868

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Camptothecin DNA Topoisomerase I Inhibitors in Cancer Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 3, 2003-01 ,pp. : 305-320

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and cytotoxicity of novel 20-O-linked homocamptothecin ester derivatives as potent topoisomerase I inhibitors

By Li Di-Zao   Wang Cun-Ying   Liu Rui-Hua   Wang Yan-Ming   Ji Teng-Fei   Li Yu-Rong   Pan Xian-Dao  

Journal of Asian Natural Products Research, Vol. 15, Iss. 11, 2013-11 ,pp. : 1179-1188

Taylor & Francis Ltd

Access to resources Recommend Favorite